Article info
PDFPostScript
PostScript
Response to: ‘Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma’ by Li
- Correspondence to Dr Richard C Turkington, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, UK; r.turkington{at}qub.ac.uk
Citation
Response to: ‘Unified definition of relapse-free survival should be used for evaluating survival benefit in oesophageal adenocarcinoma’ by Li
Publication history
- Received June 4, 2020
- Accepted June 8, 2020
- First published June 30, 2020.
Online issue publication
May 24, 2021
Article Versions
- Previous version (5 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.